YY1 and neoplasm: One small molecule that has been investigated for its potential as a YY1 inhibitor is DETA-NONOate, which was reported in both in vitro and in vivo studies to inhibit the activities of YY1 and Bcl-xL, two proteins that can help tumor cells resist chemotherapy [150,164].